Company Profile

Stellar Biotechnologies Inc
Profile last edited on: 7/2/18      CAGE: 47AQ0      UEI: GLHVZ2GMBX47

Business Identifier: Sustainable manufacture of Keyhole Limpet Hemocyanin (KLH) protein
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

332 East Scott Street
Port Hueneme, CA 93401
Location: Single
Congr. District: 24
County: San Luis Obispo

Public Profile

Stellar Biotechnologies, Inc., a biotechnology company, engaged in the aquaculture, R&D, manufacture, and distribution of keyhole limpet hemocyanin (KLH) protein. Providing KLH protein under the Stellar KLH brand, the company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. Products include Stellar KLH protein in various grades, formulations, custom configurations, and fill finishes for drug development and research applications, as well as KLH-based in vitro diagnostic kits for research and preclinical use. Its customers and partners comprise biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2008 2 NSF $556,199
Project Title: Megathura crenulata Post Larval Culture - Bottleneck for a Valuable Medical Resource
2007 2 NIH $4,509,194
Project Title: Technology for Culture of Megathura Crenulata for KLH

Key People / Management

  Frank R Oakes -- Founder, President and CEO

  Mary Catherine Brisson -- Chief Operating Officer

  D Brookstein

  Mark Adrian McPartland -- Vp of Corp. Devel. and Communications

  Kathi Niffenegger -- Chief Financial Officer and Corp. Sec.